Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

The Effects of the Yi Jin Jing on the Muscles and Bones of Adults

30. august 2026 opdateret af: He Jin, Beijing Hospital of Traditional Chinese Medicine
Observation of the effects of Yi Jin Jing on the muscles and bones of adults

Studieoversigt

Status

Rekruttering

Betingelser

Intervention / Behandling

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

50

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Studiesteder

  • Kina
      • Beijing, Kina
        • Rekruttering
        • No. 23, Ganju Road, Dongcheng District, Beijing
        • Kontakt:

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Voksen
  • Ældre voksen

Tager imod sunde frivillige

Ja

Beskrivelse

Inclusion Criteria:

  • Age 18-90 years inclusive;
  • Generally healthy, no acute or chronic diseases affecting major organ functions;
  • No cognitive impairment, able to understand and comply with study procedures;
  • Willing and able to provide written informed consent;
  • No pregnancy or lactation (for females);
  • No recent (within 3 months) major surgery, hospitalization, or significant weight change (>5% body weight).

Exclusion Criteria:

  • Presence of acute or unstable chronic diseases (e.g., uncontrolled hypertension, diabetes, heart failure, or malignancy);
  • Severe cognitive impairment, psychiatric disorders, or inability to follow study instructions;
  • Recent (≤3 months) major surgery, trauma, or hospitalization;
  • Pregnancy, lactation, or childbearing potential without reliable contraception;
  • Body mass index (BMI) <16 or >40 kg/m²;
  • Current use of medications affecting muscle or nutritional metabolism (e.g., corticosteroids, anabolic steroids);
  • Participation in another interventional trial within 30 days.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Forebyggelse
  • Tildeling: N/A
  • Interventionel model: Enkelt gruppeopgave
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: The effects of Yi Jin Jing on the muscles and bones of adults
Yijinjing exercise
Adfærdsmæssigt: Yijinjing
Yijinjing

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Appendicular Skeletal Muscle Index
Tidsramme: Day 180 ± 10 days
Appendicular Skeletal Muscle Index (ASMI) = appendicular lean mass (kg) / height² (m²). It reflects muscle mass, used for sarcopenia diagnosis. Lower values indicate muscle loss, linked to aging, malnutrition, or disease.
Day 180 ± 10 days

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Handgrip strength
Tidsramme: Day 180 ± 10 days
Handgrip strength (HGS) = maximum force (kg) measured by a dynamometer. It reflects overall muscle function, predicts disability, morbidity, and mortality. Low HGS indicates sarcopenia, frailty, or poor nutritional status.
Day 180 ± 10 days
Nutrition intake form（MNA）
Tidsramme: Day 180 ± 10 days

Mini Nutritional Assessment - Short Form (MNA-SF) consists of 6 items:

  • Appetite and food intake - assesses whether food intake has decreased over the past 3 months.
  • Weight loss - records recent unintentional weight loss.
  • Mobility - determines whether the person can walk independently or is bedridden.
  • Acute disease or psychological stress - checks for stressful events in the past 3 months.
  • Neuropsychological problems - identifies dementia, depression, or other mental disorders that affect eating.
  • Body mass index (BMI) or calf circumference - reflects body fat reserves and muscle mass.

Each item scores 0-3 points. A total score ≤11 indicates a risk of malnutrition. It is commonly used for nutritional screening in elderly populations.
Day 180 ± 10 days
Fried
Tidsramme: Day 180 ± 10 days
Fried Frailty Phenotype = a 5-item scale assessing unintentional weight loss, exhaustion, low grip strength, slow walking speed, and low physical activity. item ≥3 = frail; 1-2 = prefrail; 0 = robust. Predicts falls, disability, and mortality.
Day 180 ± 10 days
FRAIL
Tidsramme: Day 180 ± 10 days
FRAIL Scale = a 5-item questionnaire: Fatigue, Resistance (climb stairs), Ambulation (walk), Illness (≥5 chronic conditions), and Loss of weight (≥5%). Score 0 = robust, 1-2 = prefrail, 3-5 = frail. Quick screening for frailty in community settings.
Day 180 ± 10 days
SPPB
Tidsramme: Day 180 ± 10 days
Short Physical Performance Battery (SPPB) = a 3-component test: standing balance (0-4), 4-meter gait speed (0-4), and 5-repetition chair stand (0-4). Total score 0-12; ≤8 indicates poor physical function, predicts disability, falls, and mortality in older adults.
Day 180 ± 10 days
Muscle mass measured by ultrasound
Tidsramme: Day 180 ± 10 days

Ultrasound-based measurements of peripheral skeletal muscles offer a practical, non-invasive, and radiation-free approach for assessing muscle mass in clinical and research settings. In accordance with previously established cut-off values, the following parameters are employed to identify a tendency toward reduced muscle mass:

  1. Biceps brachii cross-sectional area (CSA) - a male-specific indicator, with a value < 7.1 cm² suggesting reduced muscle mass;
  2. Tibialis anterior muscle thickness (MT) - a female-specific indicator, with a value < 2.3 cm suggesting reduced muscle mass;
  3. Rectus femoris muscle thickness (MT) - a gender-neutral rapid screening index, with a value < 1.3 cm serving as a universal cut-off for both men and women, indicating a tendency toward low muscle mass.

These ultrasonographic parameters are intended for initial screening and may assist in the early identification of individuals at risk for sarcopenia, particularly when access to dual-energy X-ray abs
Day 180 ± 10 days

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Beijing Hospital of Traditional Chinese Medicine

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Anslået)

1. september 2026

Primær færdiggørelse (Anslået)

31. december 2027

Studieafslutning (Anslået)

31. december 2028

Datoer for studieregistrering

Først indsendt

4. august 2026

Først indsendt, der opfyldte QC-kriterier

4. august 2026

Først opslået (Faktiske)

7. august 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

1. september 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

30. august 2026

Sidst verificeret

1. august 2026

Mere information

Begreber relateret til denne undersøgelse

Nøgleord

Andre undersøgelses-id-numre

  • 2025BL02-161-02

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

UBESLUTET

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner